Features of myocardial damage at COVID-19
https://doi.org/10.38109/2225-1685-2022-3-66-72
Abstract
This work is devoted to a literature review of published articles, where studies are focused on studying the frequency, structure of complications of cardiovascular diseases in patients with COVID-19, that occurred in vivo and post-mortem: myocarditis, myocardial damage, AMI, and other thrombotic events. Some studies also provide comparative data on COVID-19+ and COVID-19- patients, complication patterns, and mortality rates. The results of the studied materials shows that, the frequency of cardiac complications and the number of deaths are significantly more common in patients with concomitant diseases such as arterial hypertension, diabetes mellitus, obesity, CKD, arrhythmias. Patients over 60 years of age are at increased risk of a severe course of the disease, this is due to the fact that these individuals have concomitant chronic diseases that are decompensated due to an acute infectious process, reducing the adaptive capabilities of the organism, and lead to a deterioration in survival rates.
Supporting agencies: The article was not funded. The article is part of the dissertation work
About the Authors
S. H. Hamidov
Saint Petersburg State University; City Hospital № 40
Russian Federation
Russian Federation
Sardor H. Hamidov, postgraduate student, 2nd year resident, trainee doctor
2nd year of study
Infectious diseases department No. 2
199034
University nab., 7/9
197706
9A Borisova Street
Saint-Petersburg
spbu.ru
gb40.ru
A. G. Obrezan
Saint Petersburg State University; International Medical Centre “SOGAZ”
Russian Federation
Russian Federation
Andrey G. Obrezan, MD, Head of the Department, Chief Physician
Faculty of Medicine
Department of Hospital Therapy
199034
University nab., 7/9
191186
Malaya Konyushennaya str., 8
Saint-Petersburg
spbu.ru
sogaz-clinic.ru
P. S. Lobanova
S. P. Botkin Saint Petersburg Infectious Diseases Hospital
Russian Federation
Russian Federation
Polina S. Lobanova, infectious diseases doctor
195067
Piskarevsky ave., 49
Saint-Petersburg
S. V. Azarenko
Multi-field Clinic «Sestroretskaya
Russian Federation
Russian Federation
Sergey V. Azarenko, Chief Medical Officer
197706
Border Guards str., 2 building 1
Sestroretsk
References
1. Bavishi C., Bonow R. O., Trivedi V., Abbott J. D., Messerli F. H., Bhatt D. L. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020; 63 (5): 682-689. https://doi.org/10.1016/j.pcad.2020.05.013
2. Halushka M. K., Vander Heide R. S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021; 50: 107300. PMID: 33132119. https://doi.org/10.1016/j.carpath.2020.107300
3. Благова О. В. Оценка уровня антикардиальных антител у больных с тяжелым и среднетяжелым течением COVID-19 (корреляции с клинической картиной и прогнозом) / О. В. Благова [и др.] // Российский кардиологический журнал. – 2020. – 25 (11): 4054.. [Blagova O. V., Varionchik N. V., Zaydenov V. A., Savina P. O., Sarkisova N. D. Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis). Russian Federationn Journal of Cardiology. 2020; 25 (11): 4054. (In Russ.)]. https://doi.org/10.15829/29/1560-4071-2020-4054
4. Chung, Mina K. et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circulation research vol. 128, 8 (2021): 1214-1236. https://doi.org/10.1161/CIRCRESAHA.121.317997
5. The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group, Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries, European Heart Journal, 2021; ehab656. https://doi.org/10.1093/eurheartj/ehab656
6. Linschoten M., Peters S., van Smeden M., et al. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care. 2020; 9 (8): 817-823. PMID: 33222494. https://doi.org/10.1177/2048872620974605
7. Сережина Е. К. Патофизиологические механизмы и нозологические формы сердечно-сосудистой патологии при COVID-19 / Е. К. Сережина, А. Г. Обрезан // Кардиология. – 2020. – 60 (8): 23-26. [Serezhina E. K., Obrezan A. G. Cardiovascular Pathology in Patients With COVID-19. Kardiologiia. 2020; 60 (8): 23-26. (In Russ.)]. https://doi.org/10.18087/cardio.2020.8.n1215
8. Pinto D. S. (2021). COVID-19: Myocardial infarction and other coronary artery disease issues. UpToDate. Retrieved April, 2022, from https://www.uptodate.com/contents/covid-19-myocardial-infarction-and-other-coronary-artery-disease-issues#H2554956222
9. Thygesen K., Alpert J. S., Jaffe A. S., et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72 (18): 2231-2264. https://doi.org/10.1016/j.jacc.2018.08.1038
10. James L. Januzzi Jr., MD, FACC. Troponin and BNP Use in COVID-19. Mar 18, 2020 Cardiology Magazine. https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnp-use-in-covid19
11. Abate S. M., Mantefardo B., Nega S., Chekole Y. A., Basu B., Ali S. A., Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond). 2021 Aug; 68: 102594. PMID: 34336202. https://doi.org/10.1016/j.amsu.2021.102594
12. Bonow R. O., Fonarow G. C., O’Gara P. T., Yancy C. W. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020; 5 (7): 751–753. https://doi.org/10.1001/jamacardio.2020.1105
13. Giustino G., Croft L. B., Stefanini G. G., et al. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol. 2020; 76 (18): 2043-2055. PMID: 33121710. https://doi.org/10.1016/j.jacc.2020.08.069
14. De Michieli L., Ola O., Knott J. D., et al. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19. Clinical Chemistry. 2021 Aug; 67 (8): 1080-1089. PMID: 33860295. https://doi.org/10.1093/clinchem/hvab062
15. Poterucha T. J., Elias P., Jain S. S., et al. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc. 2021; 10 (1): e018476. https://doi.org/10.1161/JAHA.120.018476
16. Bardají A., Carrasquer A., Sánchez-Giménez R., et al. Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital. Rev Esp Cardiol (Engl Ed). 2021; 74 (1): 24-32. PMID: 33144126. https://doi.org/10.1016/j.recesp.2020.08.009
17. Metkus T. S., Sokoll L. J., Barth A. S., et al. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021; 143 (6): 553-565. https://doi.org/10.1161/CIRCULATIONAHA.120.050543
18. Терещенко С. Н. Диагностика и лечение миокардитов / С. Н. Терещенко [и др.] // Евразийский Кардиологический Журнал. – 2019. – (3): 4-33. [Tereshchenko S. N., Zhirov I. V., Masenko V. P., Narusov O. Yu., Nasonova S. N., Samko A. N., Stukalova O. V., Shariya M. A. DIAGNOSIS AND TREATMENT OF MYOCARDITIDES. Eurasian heart journal. 2019; (3): 4-33. (In Russ.).] https://doi.org/10.38109/2225-1685-2019-3-4-33
19. Boehmer T. K., Kompaniyets L., Lavery A. M., et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021; 70 (35): 1228-1232. Published 2021 Sep 3. http://dx.doi.org/10.15585/mmwr.mm7035e5
20. Siripanthong B., Nazarian S., Muser D., et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020; 17 (9): 1463-1471. PMID: 32387246. https://doi.org/10.1016/j.hrthm.2020.05.001
21. Kociol R. D., Cooper L. T., Fang J. C., et al. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020; 141 (6): e69-e92. https://doi.org/10.1161/CIR.0000000000000745
22. Inciardi R. M., Lupi L., Zaccone G., et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 819-824. PMID: 32219357. URL: https://pubmed.ncbi.nlm.nih.gov/32219357/
23. In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han, COVID-19-related myocarditis in a 21-year-old female patient, European Heart Journal, Volume 41, Issue 19, 14 May 2020, Page 1859, https://doi.org/10.1001/jamacardio.2020.1096
24. Ammirati E., Lupi L., Palazzini M., et al. Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis. Circulation. 2022; 145 (15): 1123-1139. PMID: 35404682. https://doi.org/10.1161/CIRCULATIONAHA.121.056817
25. Eiros R., Barreiro-Pérez M., Martín-García A., et al. Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers [published online ahead of print, 2021 Nov 5]. Rev Esp Cardiol (Engl Ed). 2021; S1885-5857(21)00324-8. PMID: 34866030. https://doi.org/10.1016/j.rec.2021.11.001
26. Rajpal S., Tong M. S., Borchers J., et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021; 6 (1): 116–118. https://doi.org/10.1001/jamacardio.2020.4916
27. Starekova J., Bluemke D. A., Bradham W. S., et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021; 6 (8): 945-950. https://doi.org/10.1001/jamacardio.2020.7444
28. Diaz G. A., Parsons G. T., Gering S. K., Meier A. R., Hutchinson I. V., Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021; 326 (12): 1210–1212. https://doi.org/10.1001/jama.2021.13443
29. Montgomery J., Ryan M., Engler R., et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021; 6 (10): 1202–1206. https://doi.org/10.1001/jamacardio.2021.2833
30. Witberg G., Barda N., Hoss S., et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med. 2021; 385 (23): 2132-2139. https://doi.org/10.1056/NEJMoa2110737
31. Solomon M. D., McNulty E. J., Rana J. S., et al. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020; 383 (7): 691-693. https://doi.org/10.1056/NEJMc2015630
32. Smilowitz N. R., Subashchandran V., Yuriditsky E., Horowitz J. M., Reynolds H. R., Hochman J. S., Berger J. S. Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19. Am Heart J. 2021 Jan; 231: 93-95. PMID: 33181067. https://doi.org/10.1016/j.ahj.2020.10.075
33. Rashid M., Wu J., Timmis A., et al. Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med. 2021; 290 (1): 88-100. https://doi.org/10.1111/joim.13246
34. Rodriguez-Leor O., Cid Alvarez A. B., Pérez de Prado A., et al. Inhospital outcomes of COVID-19 ST-elevation myocardial infarction patients. EuroIntervention. 2021; 16 (17): 1426-1433. https://doi.org/10.4244/EIJ-D-20-00935
35. Saad M., Kennedy K. F., Imran H., et al. Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021; 326 (19): 1940-1952. https://doi.org/10.1001/jama.2021.18890
36. Abate S. M., Mantefardo B., Nega S., Chekole Y. A., Basu B., Ali S. A., Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond). 2021 Aug; 68: 102594. https://doi.org/10.1016/j.amsu.2021.102594
37. Manolis A. S., Manolis A. A., Manolis T. A., Melita H. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges. Journal of Cardiovascular Pharmacology and Therapeutics. September 2021: 399-414. https://doi.org/10.1177%2F10742484211011026
38. Kogan E, Berezovskiy Y., Blagova O., Kukleva A., Semyonova L., Gretsov E., Ergeshov A. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn Pathol. 2022 Feb 17; 17 (1): 31. PMID: 35177093. https://doi.org/10.1186/s13000-022-01207-6
39. Wallace M., Oliver S. COVID-19 mRNA vaccines in adolescents and young adults: benefit-risk discussion. Presented at the Advisory Committee on Immunization Practices Meeting, Atlanta, June 23–25, 2021 (https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/05-COVID-Wallace-508.pdf opens in new tab).
40. Primessnig, U., Pieske, B. M., and Sherif, M. (2021) Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic. ESC Heart Failure, 8: 333-343. https://doi.org/10.1002/ehf2.13075
41. Watanabe Y., Miyachi H., Mozawa K., et al. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo. Intern Med. 2021; 60 (23): 3693-3700. https://doi.org/10.2169/internalmedicine.8220-21
42. Paul Jie Wen Tern, Yilin Jiang, Yee How Lau, Wael Almahmeed, S. Gunavathy Selvaraj, Jack Wei Chieh Tan, Wan Azman Wan Ahmad, Jonathan Yap, Khung Keong Yeo, MBBS. Impact of COVID-19 on Acute MI and Percutaneous Coronary Intervention Rates and Outcomes in South East Asia and the Middle East. Journal of Asian Pacific Society of Cardiology 2022; 1: e05. https://doi.org/10.15420/japsc.2021.12
43. Jabagi M. J., Botton J., Bertrand M., et al. Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. 2022; 327 (1): 80–82. https://doi.org/10.1001/jama.2021.21699
44. Y. N. Aye, A. S. Mai, A. Zhang, O. Z. H. Lim, N. Lin, C. H. Ng, M. Y. Chan, J. Yip, P.-H. Loh, N. W. S. Chew, Acute myocardial infarction and myocarditis following COVID-19 vaccination, QJM: An International Journal of Medicine, 2021; hcab252, https://doi.org/10.1093/qjmed/hcab252
Review
For citations:
Hamidov S.H., Obrezan A.G., Lobanova P.S., Azarenko S.V. Features of myocardial damage at COVID-19. Eurasian heart journal. 2022;(3):66-72. (In Russ.) https://doi.org/10.38109/2225-1685-2022-3-66-72
Views:
405
Email this article 
